Telemedicine During the COVID-19 Pandemic: A Paradigm Shift in Non-Communicable Disease Management? – A Cross-Sectional Survey from a Quaternary-Care Center in South India

Autor: Ullas S, Pradeep M, Surendran S, Ravikumar A, Bastine AM, Prasad A, Mohan A

Publikováno v: Patient Preference and Adherence, Vol Volume 15, Pp 2715-2723 (2021)

Sisira Ullas,1 Manu Pradeep,2 Sandeep Surendran,3 Anjali Ravikumar,4 Anna Maria Bastine,1 Ayush Prasad,1 Aravind Mohan1 1Amrita School of Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India; 2Department of

Externí odkaz: https://doaj.org/article/72c1c1395c5b44a1829bb14bb680d74e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Applications of Flow Cytometry in Drug Discovery and Translational Research.

Autor: Ullas S; Flagship Pioneering, 140 First Street, Cambridge, MA 02141, USA., Sinclair C; Flagship Pioneering, 140 First Street, Cambridge, MA 02141, USA.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 29; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 29.

A modified mouse model of Friedreich's ataxia with conditional Fxn allele homozygosity delays onset of cardiomyopathy.

Autor: Perfitt TL; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Huichalaf C; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Gooch R; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Kuperman A; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Ahn Y; Target Sciences, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Chen X; Comparative Medicine, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Ullas S; Comparative Medicine, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Hirenallur-Shanthappa D; Comparative Medicine, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Zhan Y; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Otis D; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Whiteley LO; Drug Safety Research and Development, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Bulawa C; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States., Martelli A; Rare Disease Research Unit, Worldwide Research, Development and Medical, Pfizer, Incorporated, Cambridge, Massachusetts, United States.

Publikováno v: American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2024 Feb 01; Vol. 326 (2), pp. H357-H369. Date of Electronic Publication: 2023 Dec 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.